Progyny, Inc. EV/FCF

EV/FCF of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current EV/FCF of Progyny, Inc. is 101.5 (as of December 30, 2020)
  • EV/FCF for the quarter ending June 29, 2021 was 368.65 (a 132.13% increase compared to previous quarter)
  • Year-over-year quarterly EV/FCF increased by 216.85%
  • Annual EV/FCF for 2020 was 101.5 (a -192.34% decrease from previous year)
  • Annual EV/FCF for 2019 was -109.92 (a -780.66% decrease from previous year)
  • Annual EV/FCF for 2018 was 16.15 (a 0.0% decrease from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Progyny, Inc.

Most recent EV/FCFof PGNY including historical data for past 10 years.

Interactive Chart of EV/FCF of Progyny, Inc.

Progyny, Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 368.65 158.81
2020 101.5 116.35 188.16 128.61 101.5
2019 -109.92 16.15 16.15 16.15 -109.92
2018 16.15 16.15
2017 16.15

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.